# Arnold G. Vulto

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/arnold-g-vulto/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,754 |
| Field | Biosimilars and Bioanalytical Methods |
| h-index | 58 |
| i10-index | 168 |
| Last Known Institution | Erasmus MC |
| OpenAlex ID | https://openalex.org/A5016982472 |
| ORCID iD | 0000-0002-8439-2800 |
| Works | 343 |

## Researcher papers

- [Overriding of Drug Safety Alerts in Computerized Physician Order Entry](https://scholariq.org/papers/overriding-of-drug-safety-alerts-in-computerized-physician-order-entry/)
- [Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience](https://scholariq.org/papers/treatment-of-metastatic-renal-cell-carcinoma-with-autologous-t-lymphocytes/)
- [Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity](https://scholariq.org/papers/treatment-of-metastatic-renal-cell-carcinoma-with-caix-car-engineered-t-cells/)
- [Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk](https://scholariq.org/papers/long-term-intravenous-treatment-of-pompe-disease-with-recombinant-human/)
- [Policies for biosimilar uptake in Europe: An overview](https://scholariq.org/papers/policies-for-biosimilar-uptake-in-europe-an-overview/)
- [Recombinant human α-glucosidase from rabbit milk in Pompe patients](https://scholariq.org/papers/recombinant-human-glucosidase-from-rabbit-milk-in-pompe-patients/)
- [Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial](https://scholariq.org/papers/aerosolized-liposomal-amphotericin-b-for-the-prevention-of-invasive-pulmonary/)
- [glycyrrhizin as a potential treatment for chronic hepatitis C](https://scholariq.org/papers/glycyrrhizin-as-a-potential-treatment-for-chronic-hepatitis-c/)
- [Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐up](https://scholariq.org/papers/enzyme-replacement-therapy-in-late-onset-pompe-s-disease-a-three-year-follow-up/)
- [Spironolactone in type 2 diabetic nephropathy: effects on proteinuria, blood pressure and renal function](https://scholariq.org/papers/spironolactone-in-type-2-diabetic-nephropathy-effects-on-proteinuria-blood/)

## Researcher topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)

## Researcher university

- [Erasmus MC](https://scholariq.org/institutions/erasmus-mc/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.